Abstract
The effects of azelastine on histamine- and leukotriene C4 and D4 (LTC4, LTD4)-induced contractile responses in isolated guinea pig ileum were investigated. Following a 2-min contact with the ileum, azelastine produced competitive antagonism of histamine (pA2=8.24). Following a 15-min contact, azelastine at 2.5×10−9 M exerted competitive antagonism, but at higher concentrations (10, 40 and 160×10−9M) it not only shifted histamine concentration-effect curves to the right but also suppressed its maximum. Thus, azelastine exerts a dual (competitive/noncompetitive) antagonism of histamine depending upon the concentration and duration of contact. Azelastine and FPL 55712 (a known LT receptor antagonist) produced concentration-dependent antagonism of LTC4 and LTD4. Azelastine and compound FPL 55712 also exerted concentration-dependent reversal (relaxation) of pre-existing LTC4-induced contractions. In conclusion, the potent H1-histamine and leukotriene receptor blocking activities of azelastine may contribute to its antiasthmatic/antiallergic activities.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. P. Kemp, E. O. Meltzer, H. A. Orgel, M. J. Welch, R. F. Lockey, E. Middleton, Jr., S. L. Spector, J. L. Perhach and J. J. Newton,A Dose-Response Study of the Bonchodilator Action of Azelastine in Asthma. J. Allergy Clin. Immunol.77, 249 (1986).
S. Motojima, Y. Ohashi, T. Otsuka, T. Fukuda and S. Makino,Effects of Azelastine on Allergen- and Exercise-Induced Asthma. Asian Pacific J. Allergy Immunol.3, 174–178 (1985).
S. Spector, A. Rohr, G. Rachelefsy, R. Katz, S. Siegle, J. Perhach and J. Newton,Pharmacodynamic Evaluation of Azelastine in Asthmatics. J. Allergy Clin. Immunol.77, 249 (1986).
J. T. Connell, J. L. Perhach, J. M. Weiler, R. Rosenthale, L. Hamilton, L. Diamond and J. J. Newton,Azelastine a New Antiallergic Agent: Efficacy in Ragweed Hay Fever. Annals of Allergy55, 392 (1985).
C. A. Gould, S. Ollier and R. J. Davies,The Effect of Single and Multiple Dose Therapy With Azelastine on the Immediate Asthmatic Response to Allergen Provocation Testing. Annals of Allergy55, 232 (1985).
W. Storms, E. Middleton, D. Dvorin, J. Kemp, S. Spector, J. Newton and J. L. Perhach,Azelastine (AZEL) in the Treatment of Asthma. J. Allergy Clin. Immunol.75, 167 (1985).
J. Perhach, J. Connell, L. Hamilton, L. Diamond, J. Weiler and J. Melvin,Multicenter Trial of Azelastine in Allergic Rhinitis. J. Allergy Clin. Immunol.73, 144 (1984).
A. Mandi, Y. G. Galgoc, E. Galambos and R. Aurich,Histamine Protection and Bronchodilation With Azelastine a New Antiallergic Compound. Bull. Europ. Physiopathy. Res.17, 5P (1981).
P. Atkins, H. Merton, P. Karpink, I. Weliky and B. Zweiman,Azelastine Inhibition of Skin Test Reactivity in Humans. J. Allergy Clin. Immunol.75, 167 (1985).
W. Diamantis, N. Chand, J. E. Harrison, J. Pillar, J. L. Perhach and R. D. Sofia,Inhibition of release of SRS-A and its antagonism by azelastine (A), an H 1 antagonist-antiallergic agent. Pharmacologist24, 200 (1982).
N. Chand, K. Nolan, W. Diamantis, J. L. Perhach, Jr. and R. D. Sofia,Inhibition of Leukotriene (SRS-A)-Mediated Allergic Bronchospasm by Azelastine, A Novel Orally Effective Antiasthmatic Drug. J. Allergy Clin. Immunol.71, 149 (1983).
N. Chand, J. E. Harrison, S. M. Rooney, R. D. Sofia and W. Diamantis,Inhibition of Passive Cutaneous Anaphylaxis (PCA) by Azelastine: Dissociation of its Antiallergic Activities From Antihistaminic and Antiserotonin Properties. Int. J. Immunopharmacol.7, 833–838 (1985).
N. Chand, J. Pillar, W. Diamantis and R. D. Sofia,Inhibition of Allergic Histamine Release by Azelastine and Selected Antiallergic Drugs From Rabbit Leukocytes. Int. Archs. Allergy Appl. Immunol.77, 451–455 (1985).
K. Taniguchi and K. Takanara,Inhibitory Effects of Various Drugs on Phorbol Myristate Acetate and n-Formyl Methionyl Leucyl Phenylalanine Induced O −2 Production in Polymorphonuclear Leukocytes. Biochem. Pharmacol.33, 3165–3169 (1984).
J. M. Van Rossum,Cumulative Dose-Response Curves. II. Technique For the Making of Dose-Response Curves in Isolated Organs and the Evaluation of Drug Parameters. Arch. int. Pharmacodyn.143, 299–349 (1963).
J. H. Gaddum, K. A. Hameed, H. E. Hathway and F. F. Stephen,Quantitative Studies of Antagonists for 5-Hydroxytryptamine. Q. J. Expt. Physiol.40, 49–74 (1955).
O. Arunlakshana and H. O. Schild,Some Quantitative Uses of Drug Antagonists. Br. J. Pharmacol.14, 48–58 (1959).
C. Labrid, G. Dureng, P. Duchene-Marullaz and J. Moleyre,Dualist or Pseudo-Dualist Interactions of Mepyramine, Diphenhydramine and Eprozinol With Histamine at H 1-Receptors. Jap. J. Pharmacol.27, 491–500 (1977).
T. P. Kenakin,The Classification of Drugs and Drug Receptors in Isolated Tissues. Pharmacol. Rev.36, 165–222 (1984).
B. Samuelsson,Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation. Science220, 568–575 (1983).
N. Chand and B. M. Altura,Lipoxygenase Pathway and Hydroperoxy Acids: Possible Relevance to Aspirin-Induced Asthma and Hyperirritability of Airways in Asthmatics. Prostag. & Med.6, 249–256 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chand, N., Diamantis, W. & Sofia, R.D. Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum. Agents and Actions 19, 164–168 (1986). https://doi.org/10.1007/BF01966201
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01966201